Sponsored By

For information on becoming a sponsor or exhibitor, please click here.


APR 10, 2019

Molecular Diagnostics 2019





 

Our 4th Annual Molecular Diagnostics Virtual Event is now available On-Demand! The event will remain open 6 months from the date of the live event.  The webinars will be available for unlimited on-demand viewing.

This premiere, online-only, event is free to attend and brought together the molecular diagnostics community to discuss and present the newest advances in molecular diagnostics testing.

Topic's for this years event included: 

  • Best Practices in Establishing Value in Laboratory Testing
    • Paradigm Shift in the Laboratory: Surviving in the Era of Change
  • Disruptive Molecular Technologies
    • Latest Advancements in Next Generation Sequencing
    • Advancements in Biosensors
  • Digital Diagnostics and Artificial Intelligence

Continuing Education
LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this event, you can earn 1 Continuing Education credit per presentation for a maximum of 14 credits.

Use #LRmoldx to follow the conversation!


Speakers

Show Resources
You May Also Like
NOV 14, 2019 06:00 AM PST
C.E. CREDITS
NOV 14, 2019 06:00 AM PST
Ten years ago LabRoots launched a new system of learning for a global scientific audience. Now, the 2019 Clinical Diagnostics and Research Virtual Event will again bring together clinicians,...
JUN 20, 2019 06:00 AM PDT
C.E. CREDITS
JUN 20, 2019 06:00 AM PDT
LabRoots and the Precision Medicine Planning Committee are pleased to announce the 4th Annual Precision Medicine Virtual Event. Precision Medicine 2019, a two-day event held June 19-20, will...
AUG 22, 2019 06:00 AM PDT
C.E. CREDITS
AUG 22, 2019 06:00 AM PDT
LabRoots is pleased to announce a new addition to our virtual conference line up for 2019, Forensics & Toxicology! The exciting field of Forensics/Toxicology is focused on a blend of biology...
SEP 11, 2019 06:00 AM PDT
C.E. CREDITS
SEP 11, 2019 06:00 AM PDT
LabRoots and the Microbiology Planning Committee is bringing the microbiology research community together at the 5th Annual Microbiology and Immunology Virtual Event! During the free, two-day...
SEP 26, 2019 06:00 AM PDT
C.E. CREDITS
SEP 26, 2019 06:00 AM PDT
LabRoots and the Cell Biology Planning Committee are please to announce the 3rd Annual Cell Biology Virtual Event, providing an opportunity to discuss recent discoveries in biological researc...
NOV 12, 2020 06:00 AM PST
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
NOV 12, 2020 06:00 AM PST
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
Ten years ago LabRoots launched a new system of learning for a global scientific audience. Now, the 2020 Clinical Diagnostics and Research Virtual Event will again bring together clinicians,...
Agenda
  • APR 10, 2019 06:00 AM PDT
    Speaker: Duane Newton, PhD, D(ABMM), FIDSA
    Sponsored By: Bio-Rad Laboratories
  • APR 10, 2019 06:00 AM PDT
    Omar Abudayyeh, PhD
    MIT McGovern Institute Fellow
    Jonathan Gootenberg, PhD
    MIT McGovern Institute Fellow, Massachusetts Institute...
  • APR 10, 2019 07:30 AM PDT
    Speaker: Michael Crossey, MD, PhD
  • APR 10, 2019 09:00 AM PDT
    Speaker: James Broughton
  • APR 10, 2019 09:00 AM PDT
    Speaker: Esther Babady, PhD
  • APR 10, 2019 09:00 AM PDT
    Speaker: Morgan Pence, PhD, D(ABMM)
    Sponsored By: DiaSorin Molecular
  • APR 10, 2019 10:30 AM PDT
    Sponsored By: QIAGEN
    Anika Joecker, PhD
    Associate Director Global Product Management NGS, QIAGE...
    Jennifer Poitras, PhD
    Principal Genome Scientist, Bioinformatics - Genetic Di...
  • APR 10, 2019 10:30 AM PDT
    Sponsored By: QIAGEN
    Sheryl Elkin, PhD
    Chief Scientific Officer, N-of-One, A QIAGEN Company
    Dan Richards, PhD
    Vice President, Biomedical Informatics, QIAGEN
  • APR 10, 2019 10:30 AM PDT
    Speaker: Kiana Aran, PhD
  • APR 10, 2019 12:00 PM PDT
    Sponsored By: Illumina
    Tony Magliocco, MD
    Executive Director of the Advanced Diagnostic Laborator...
    Keith Gligorich, PhD
    Laboratory Operations Director, Navican Precision Cance...
  • APR 10, 2019 12:00 PM PDT
    Speaker: Brett Goldsmith, PhD
  • APR 10, 2019 12:00 PM PDT
    Speaker: Shidong Jia, MD, PhD
  • APR 10, 2019 01:30 PM PDT
    Sponsored By: QIAGEN
    Véronique Laloux, PhD
    Senior Global Product Manager of Personalized Healthcar...
    Beate Litzenburger, PhD
    Product Owner of QIAGEN Clinical Insight (QCI™) Intepre...
  • APR 10, 2019 01:30 PM PDT
    Elizabeth Marlowe, PhD, D(ABMM)
    Global Director of Medical Affairs, Microbiology , Roch...
    Joanna Sickler, MPH, MBA
    Director of Medical Affairs, Point-of-Care, Roche Molec...
  • APR 10, 2019 01:30 PM PDT
    Speaker: Eugean Jiwanmall, MPH, MBA
  • Best Practices in Establishing Value in Laboratory Testing
  • APR 10, 2019 06:00 AM PDT
    Speaker: Duane Newton, PhD, D(ABMM), FIDSA
    Sponsored By: Bio-Rad Laboratories
  • APR 10, 2019 07:30 AM PDT
    Speaker: Michael Crossey, MD, PhD
  • APR 10, 2019 09:00 AM PDT
    Speaker: Morgan Pence, PhD, D(ABMM)
    Sponsored By: DiaSorin Molecular
  • APR 10, 2019 12:00 PM PDT
    Sponsored By: Illumina
    Tony Magliocco, MD
    Executive Director of the Advanced Diagnostic Laborator...
    Keith Gligorich, PhD
    Laboratory Operations Director, Navican Precision Cance...
  • APR 10, 2019 01:30 PM PDT
    Elizabeth Marlowe, PhD, D(ABMM)
    Global Director of Medical Affairs, Microbiology , Roch...
    Joanna Sickler, MPH, MBA
    Director of Medical Affairs, Point-of-Care, Roche Molec...
  • APR 10, 2019 01:30 PM PDT
    Speaker: Eugean Jiwanmall, MPH, MBA
  • Disruptive Molecular Technologies
  • APR 10, 2019 06:00 AM PDT
    Omar Abudayyeh, PhD
    MIT McGovern Institute Fellow
    Jonathan Gootenberg, PhD
    MIT McGovern Institute Fellow, Massachusetts Institute...
  • APR 10, 2019 09:00 AM PDT
    Speaker: James Broughton
  • APR 10, 2019 09:00 AM PDT
    Speaker: Esther Babady, PhD
  • APR 10, 2019 10:30 AM PDT
    Sponsored By: QIAGEN
    Anika Joecker, PhD
    Associate Director Global Product Management NGS, QIAGE...
    Jennifer Poitras, PhD
    Principal Genome Scientist, Bioinformatics - Genetic Di...
  • APR 10, 2019 10:30 AM PDT
    Speaker: Kiana Aran, PhD
  • APR 10, 2019 12:00 PM PDT
    Speaker: Brett Goldsmith, PhD
  • APR 10, 2019 12:00 PM PDT
    Speaker: Shidong Jia, MD, PhD
  • APR 10, 2019 01:30 PM PDT
    Sponsored By: QIAGEN
    Véronique Laloux, PhD
    Senior Global Product Manager of Personalized Healthcar...
    Beate Litzenburger, PhD
    Product Owner of QIAGEN Clinical Insight (QCI™) Intepre...
  • Digital Diagnostics and Artificial Intelligence
  • APR 10, 2019 10:30 AM PDT
    Sponsored By: QIAGEN
    Sheryl Elkin, PhD
    Chief Scientific Officer, N-of-One, A QIAGEN Company
    Dan Richards, PhD
    Vice President, Biomedical Informatics, QIAGEN
Posters

POSTER SUBMISSION GUIDELINES

Virtual poster sessions offer the opportunity to present data to a global audience via a PDF poster and video summary, and discuss results with interested colleagues through email. Posters should be submitted as a PowerPoint file. Presentations should incorporate illustrative materials such as tables, graphs, photographs, and large-print text. This content is not peer-reviewed. Submission is free.


SUBMIT YOUR ABSTRACT

Enter the following information to this Submission Form:

  • Poster Title
  • Your Name
  • Your Institution
  • Your Email
  • Abstract describing the poster


All submitted abstracts will be reviewed and decisions regarding acceptance will be made as abstracts are received. You will be notified within one week of receipt about acceptance. Further details and registration materials will be provided at that time. You do not have to be present in order to have a poster displayed. Only those abstracts approved by LabRoots may display posters at this event.

If accepted, you will also have the opportunity to record a 3-5 minute summary video for each poster. LabRoots will work with each individual to create these videos. Video links and email contact information will be included on each poster displayed.

Questions? Email Posters@LabRoots.com

LabRoots Policy

Speakers

  • Omar Abudayyeh, PhD
    MIT McGovern Institute Fellow
    Biography
      Omar Abudayyeh is a MIT McGovern Institute Fellow where he conducts independent research on investigating novel bacterial defense systems for genome editing and gene delivery properties. He previously was at Harvard Medical School and the Harvard-MIT Health Sciences and Technology program as an MD/PhD student. He completed his doctoral work in Feng Zhang's lab at the Broad Institute of MIT and Harvard, where his research centered on novel CRISPR enzymes for applications in genome editing, therapeutics, and diagnostics. Abudayyeh's work focused on trying to uncover novel CRISPR enzymes beyond Cas9 for biotechnological applications. He co-led the discovery and characterization of multiple landmark pieces of work, including the characterization of Cpf1 for novel genome editing applications and the first single-protein RNA-guided RNA-targeting enzyme C2c2/Cas13. His follow-up work on C2c2/Cas13 biology led to the development of SHERLOCK technology, and a new set of tools for precise editing of transcripts and visualizing them in mammalian cells with potential for RNA therapeutics. Abudayyeh graduated from MIT in 2012 with a B.S. in mechanical engineering and biological engineering, where he was a Henry Ford II Scholar and a Barry M. Goldwater Scholar.
    • Michael Crossey, MD, PhD
      Chief Executive Officer and Chief Medical Officer, TriCore Reference Laboratories
      Biography
        Dr. Michael Crossey is the Chief Executive Officer and Chief Medical Officer of TriCore Reference Laboratories. He attended the University of New Mexico School of Medicine in Albuquerque, N.M., and completed his residency in anatomic and clinical pathology at the University of New Mexico Hospital. He holds a doctoral degree in environmental toxicology from the Department of Zoology and Physiology at the University of Wyoming in Laramie. Dr. Crossey began his affiliation with TriCore Reference Laboratories in 1997, during the initial phases of TriCore's formation, and has helped guide the organization's development throughout its existence. As Chief Executive Officer and Chief Medical Officer, he is responsible for the oversight of TriCore's operations and plays a key role in the organization's initiative to provide healthcare professionals with easier, more timely access to laboratory information.
      • Jonathan Gootenberg, PhD
        MIT McGovern Institute Fellow, Massachusetts Institute of Technology
        Biography
          Jonathan Gootenberg earned his bachelor's degree in mathematics and biological engineering at MIT. He received his PhD in Systems Biology from Harvard University, during which he conducted research with Aviv Regev and Feng Zhang at the McGovern Institute and Broad Institute of MIT and Harvard. During his PhD, Gootenberg focused on the development of molecular technologies for treating and sensing disease states, crossing disciplines by utilizing novel computational techniques, microbiology, biochemistry, and molecular biology to uncover new CRISPR tools, including Cas12 and Cas13. He and his co-authors developed Cas13 into a toolbox with uses in fundamental research, therapeutics, and diagnostics. These applications include RNA knockdown, imaging, the base editing platform REPAIR, and the sensitive, specific, and portable diagnostic platform SHERLOCK. He is one of the first members of the McGovern Institute Fellows program, which supports the transition to independent research for exceptional recent PhD graduates, and has received multiple awards, including Forbes 30 Under 30 and Business Insider 30 and Under.
        • Kiana Aran, PhD
          Co-Founder, Nanosens, Assistant Professor of Biomedical Sciences at Keck Graduate Institute, Visiting Assistant Professor at UC Berkeley
          Biography
            Dr. Aran just published the CRISPR-Chip technology in Nature Biomedical Engineering. The technology allows for quick insight into the human genome and potential identification of genetic disorders via a handheld device. The technology which was developed in Dr. Aran's Lab integrate the CRISPR-Cas9 complex into the new Cardea Graphene Biosensors. This is the first example of CRISPR enabled electronic sensors for genetic testing. Dr. Kiana Aran received her Ph.D. in Biomedical Engineering at Rutgers University in 2012. She then continued her postdoctoral studies in bio-engineering at the University of California Berkeley. She was a recipient of the National Institutes of Health (NIH) postdoctoral training fellowship at the Buck Institute for Age Research in 2015. She joined the Keck Graduate Institute (KGI) of Applied Life Sciences in 2017 as an Assistant Professor. For more info: www.aranlab.org
          • Esther Babady, PhD
            Director of Clinical Operations, Microbiology Service, Associate Attending Microbiologist, Departments of Medicine and Laboratory Medicine, Memorial Sloan Kettering Cancer Center
            Biography
              Dr. Esther Babady, Ph.D., D (ABMM), is the Director of Clinical Operations for the Microbiology Laboratory Service, Director of the CPEP Clinical Microbiology Fellowship program and an associate attending in the Department of Laboratory Medicine at Memorial Sloan-Kettering Cancer. She received her PhD in Biochemistry and Molecular Biology and completed a post-doctoral CPEP fellowship in Clinical Microbiology both at the Mayo Clinic in Rochester, MN. She is board certified by the American Board of Medical Microbiology (ABMM). Her research interest focuses on the development and applications of rapid, molecular diagnostics tests for detection and analysis of pathogens, particularly in immunocompromised hosts. She has published extensively on the subject including peer-reviewed manuscripts and book chapters.
            • James Broughton
              Senior Scientist, Mammoth Biosciences
              Biography
                Dr. James Broughton is a Senior Scientist at Mammoth Biosciences. James attended Cornell University for his bachelor's degree in Biology, where he began his career long interest in RNA binding proteins. He then went on to receive his doctorate from UC San Diego. During his graduate work, James applied CRISPR/Cas9 genome editing in the nematode worm C. elegans to investigate the function and specificity of microRNAs. For his postdoc, he joined the lab of Dr. Howard Chang at Stanford University. At Stanford, James examined role of RNA modifications on a newly discovered class of RNA, called circular RNAs. After his postdoc, James brought his expertise in RNA biology and CRISPR systems to Mammoth Biosciences where he works on developing and evaluating new CRISPR-based diagnostic technologies.
              • Sheryl Elkin, PhD
                Chief Scientific Officer, N-of-One, A QIAGEN Company
                Biography
                  Sheryl Krevsky Elkin, PhD, is the Chief Scientific Officer at N-of-One. As an early member of the N-of-One team, Dr. Elkin has led the interpretation of thousands of patient cases, establishing a rigorous process for the analysis of scientific and clinical evidence and presentation of molecular and clinical evidence to physicians to help guide their therapeutic decisions. For the past nine years, Dr. Elkin has taken a lead role in the development of the N-of-One clinical interpretation methodology to support clinicians in identifying therapeutic strategies specific to each patient. Prior to joining N-of-One, Dr. Elkin completed her postdoctoral fellowship at the Massachusetts Institute of Technology's Center for Cancer Research, where she earned a fellowship from the Leukemia and Lymphoma Society. Dr. Elkin earned her doctorate in Biological and Biomedical Sciences from Harvard Medical School and an A.B. in Biology and Music from Amherst College, graduating Phi Beta Kappa and summa cum laude, with High Distinction in Biology.
                • Keith Gligorich, PhD
                  Laboratory Operations Director, Navican Precision Cancer Care
                  Biography
                    Keith Gligorich, PhD, is the Laboratory Operations Director at NAVICAN Precision Cancer Care, an Intermountain Healthcare Company. NAVICAN provides TheraMap™, an end-to-end solution helping oncologists and patients harness the power of precision genomics, clinical analytics, and patient services for optimal cancer management. Prior to joining NAVICAN, Dr. Gligorich was a Research Assistant Professor in the Department of Pathology at the University of Utah and a Lead Scientist at ARUP Laboratories. In this role, he led a team of scientists focused on developing solid tumor molecular and NGS diagnostic tests. Dr. Gligorich earned a PhD in Chemistry from the University of Utah. He continued his training as a Department of Defense Breast Cancer Research Program Post-Doctoral Fellow at the Huntsman Cancer Institute.
                  • Brett Goldsmith, PhD
                    CTO, Cardea
                    Biography
                      Brett's passion is taking nanoelectronic technology out of the theoretical realm to create practical products. His scientific vision led to him founding and serving as CTO of Cardea, a company building the access ports for the Internet of Biology via graphene biosensors. Brett is one of the few people in the world with the combined expertise in biology and nanotechnology needed to develop graphene as a viable bio-electronic device. He was a lead researcher on landmark field effect biosensing papers in Science, Nature Nanotechnology, Scientific Reports, and Nature Biotechnology. His early work established coupling of biochemical systems to carbon nanotubes, for which he won the Nottingham Prize from the Physical Electronics Conference. Dr. Goldsmith earned his PhD in Chemical and Material Physics at UCI, had a postdoc fellowship at University of Pennsylvania, helped develop research programs for ONR and DARPA, and has led the technical team for the world's leading nanotechnology company.
                    • Shidong Jia, MD, PhD
                      CEO, Predicine
                      Biography
                        Shidong Jia, MD, PhD, is the Founder and CEO of Predicine. Prior to founding Predicine, Shidong spearheaded the oncology biomarker strategies and drug & diagnostics co-development at Genentech. His previous work identified p110beta as novel drug target for PTEN-deficient tumors, a finding that laid the foundation for clinical development and testing of p110beta inhibitors in cancers. He previously held various senior research positions focusing on translational and clinical cancer research at Novartis Institutes for BioMedical Research and Harvard University. Shidong was awarded the P.A.R.T. Investigatorship Award from the Dana-Farber Cancer Institute. Shidong holds a MD and PhD from Harbin Medical University and Peking Union Medical College, and completed postdoctoral training at the Dana Farber Cancer Institute - Harvard University.
                      • Eugean Jiwanmall, MPH, MBA
                        Senior Research Analyst for Medical Policy & Technology Evaluation, Independence Blue Cross
                        Biography
                          Eugean Jiwanmall's past professional experiences include basic science and clinical research. In his current role as a Senior Research Analyst for Medical Policy & Technology Evaluation at Independence Blue Cross' Claim Payment Policy Department within Facilitated Health Networks, he has served as the subject-matter-expert, writer, reviewer, communicator, presenter, consultant, adviser/facilitator, & decision-maker for hundreds of medical policy topics & technology assessments within dozens of clinical disciplines & multiple business areas. Eugean has participated in numerous roles in a number of conferences & summits etc. upon invitations. Eugean is finishing graduate work in bioethics at the University of Pennsylvania School of Medicine. He holds a bachelor's degree in biological sciences with honors from Drexel University (minor was in business administration), a master's degree of public health in evaluative clinical sciences from Dartmouth Medical School, and an MBA in health care management and economics with honors from Drexel University.
                        • Anika Joecker, PhD
                          Associate Director Global Product Management NGS, QIAGEN
                          Biography
                            Dr. Anika Joecker is Associate Director Global Product Management NGS at QIAGEN. She joined CLC bio (now QIAGEN) in 2011 as Senior Bioinformatician/Project & Team Manager and worked since 2013 in product management at QIAGEN - first in Bioinformatics and recently now as product manager of the GeneReader NGS System. Anika Joecker holds a Ph.D. in Biology/Bioinformatics from University of Cologne, Germany, and has worked as Bioinformatics Group Leader at the German Cancer Research Center (Heidelberg, Germany).
                          • Véronique Laloux, PhD
                            Senior Global Product Manager of Personalized Healthcare/Oncology at QIAGEN
                            Biography
                              Dr. Véronique Laloux is Senior Global Product Manager of Personalized Healthcare/Oncology at QIAGEN. With 15 years of experience working for molecular diagnostic industries in sales, marketing and product management roles, Véronique is responsible for onco-hematology content development of PCR (ipsogen brand) and GeneReader NGS System (QIAact brand) assays. Véronique holds a Ph.D. in Molecular Biology and Biochemistry from University Pierre et Marie Curie, Paris 6, France.
                            • Beate Litzenburger, PhD
                              Product Owner of QIAGEN Clinical Insight (QCI™) Intepret
                              Biography
                                Dr. Beate Litzenburger is the product owner of QIAGEN Clinical Insight (QCI™) Intepret. Prior to joining the QIAGEN team, Dr. Litzenburger led clinical decision support for several next generation sequencing research protocols at MD Anderson Cancer Center. In this role, Dr. Litzenburger was responsible for providing alteration interpretation, drug, and clinical trial options to clinicians. Dr. Litzenburger received her Ph.D. in molecular genetics from the University of Aachen in Germany and was a National Cancer Institute-supported post-doctoral fellow in the Department of Clinical Cancer Prevention at MD Anderson Cancer Center.
                              • Tony Magliocco, MD
                                Executive Director of the Advanced Diagnostic Laboratories, Moffitt Cancer Center
                                Biography
                                  Dr. Magliocco has over 25 years experience as a Professor, Researcher, Pathologist, Laboratory Director, Consultant, Tissue Banker, and public speaker. He is Board Certified in Anatomic Pathology and has extensive experience and sub-specialty expertise in Breast, Gyn, and Molecular Pathology. He has held continuous peer reviewed funding in translational research and his laboratory is currently investigating the mechanisms of ovarian cancer metastasis and treatment evasion. He has founded numerous molecular diagnostic laboratories in the USA and Canada, has published over 200 manuscripts in oncology, and holds numerous diagnostic technology patents. He is currently Executive Director of Esoteric Laboratory Services at the Moffitt Cancer, as well as Scientific Director for Moffitt Tissue Core, one of the largest bio banking programs in the world. He also directs the newly formed Moffitt Morsani Advanced Diagnostics Laboratories which is focused on accelerating development of new CLIA laboratory diagnostics. Dr Magliocco also directs fellowship programs in Molecular Diagnostics and Digital Pathology. He has held numerous national and international roles including Chair of Pathology for the Radiation Therapy and Oncology Clinical Trials group, member of the NCI GU steering committee, and member of the Canadian Cancer Clinical Trials Network Steering committee, as well as previous editorial position with the Journal of Surgical Oncology and is frequent reviewer for numerous other Oncology and Pathology Journals.
                                • Elizabeth Marlowe, PhD, D(ABMM)
                                  Global Director of Medical Affairs, Microbiology , Roche Molecular Systems
                                  Biography
                                    Dr. Elizabeth Marlowe is currently the Global Director of Medical Affairs for Microbiology at Roche Molecular Systems. She received her Ph.D. from the University of Arizona in 1999 and completed a Clinical/Public Health Microbiology Postdoctoral Fellowship in 2001 at the University of California Los Angeles (UCLA) David Geffen School of Medicine. Following her fellowship she continued at UCLA as an Adjunct Professor in the College of Medicine and as a Research Coordinator at the Wadsworth Anaerobe Laboratory at the West Los Angeles VA. In 2002, Dr. Marlowe joined Gen-Probe Incorporated with her primary research in the development of rapid molecular diagnostics for infectious diseases. From 2005 - 2016 she provided laboratory leadership within the Kaiser Permanente Regional Laboratories in both the Southern California region, as the Assistant Director of Microbiology, and the Northern California region, as Technical Director of Microbiology. She is a diplomat of the American Board of Medical Microbiology, past-president for the Southern California American Society for Microbiology and an Editor for the Clinical Microbiology Newsletter. She has served as a member of CLIAC, the federal advisory committee for clinical laboratory improvement amendment (CLIA) to the US Secretary of Health and Human Services. Dr. Marlowe is an elected member to the Council on Microbial Sciences for the American Society for Microbiology. Her research areas of interest are focused on the translation of new infectious disease diagnostics for use in evidence-based research for clinical and public health microbiology practice.
                                  • Duane Newton, PhD, D(ABMM), FIDSA
                                    Director, Clinical Microbiology Laboratory, Associate Director, Division of Clinical Pathology, Professor of Pathology, University of Michigan
                                    Biography
                                      Duane Newton, Ph.D., D(ABMM) is currently the Director of the Clinical Microbiology Laboratory, as well as the Associate Director of the Division of Clinical Pathology, both in the Department of Pathology at Michigan Medicine. Dr. Newton completed Post-Doctoral training at the University of Tennessee and the VA Medical Center in Memphis, Tennessee and a Clinical and Public Health Microbiology Fellowship at the University of Rochester Medical Center, Clinical Microbiology Laboratories in Rochester, New York. In 2000 he was appointed as Manager of the Virology/Immunology Section of the Department of Community Health, Division of Infectious Diseases, Bureau of Laboratories for the State of Michigan and as Adjunct Assistant Professor for the Michigan State University Medical Technology Program. In 2002, he joined the faculty of the Department of Pathology at the University of Michigan Medical School as Clinical Assistant Professor and Associate Director of the Microbiology/Virology Laboratories. Dr. Newton was named Director of Microbiology/Virology Laboratories in 2003 and received his certification as a Diplomate by the American Board of Medical Microbiology in 2004. His research interests lie in the development of molecular assays for the diagnosis and management of infectious diseases.
                                    • Morgan Pence, PhD, D(ABMM)
                                      Director, Clinical and Molecular Microbiology, Cook Children's Medical Center
                                      Biography
                                        Dr. Pence is the Director of Clinical and Molecular Microbiology at Cook Children's Medical Center in Fort Worth, Texas. Dr. Pence received her BS in Molecular and Cellular Biology from the University of Illinois at Urbana-Champaign in 2006 and her PhD in Biomedical Sciences from the University of California, San Diego in 2012. In 2014, she completed a fellowship in Clinical Microbiology at Washington University in St. Louis and joined Cook Children's Medical Center. Dr. Pence is a member of ASM, IDSA and PASCV and is the current president of the Southwestern Association of Clinical Microbiology (SWACM). Her interests include technologist and clinician education, regulatory requirements, rapid diagnostics and diagnostic stewardship.
                                      • Jennifer Poitras, PhD
                                        Principal Genome Scientist, Bioinformatics - Genetic Disease , QIAGEN
                                        Biography
                                          Jennifer received a B.S. in Genetics from the University of Connecticut and went on to receive a Ph.D. in Human Genetics at the Johns Hopkins School of Medicine. During her graduate training, she used Ingenuity Pathway Analysis and was so impressed with the tool that she approached QIAGEN for the opportunity to support their bioinformatics portfolio. Currently, she is the lead genome scientist supporting QIAGEN's software solutions for analysis and interpretation of variants implicated in hereditary disease.
                                        • Dan Richards, PhD
                                          Vice President, Biomedical Informatics, QIAGEN
                                          Biography
                                            Dan Richards is Vice President, Biomedical Informatics at QIAGEN, where he focuses on the automated interpretation of molecular variation in the context of current clinical evidence. Dan earned his Ph.D. in Human Genetics from Stanford University and co-founded Ingenuity Systems, whose analysis applications and manually-curated knowledge base of peer-reviewed scientific literature are used by scientists and clinicians worldwide to interpret genomic data in the context of current biomedical knowledge.
                                          • Joanna Sickler, MPH, MBA
                                            Director of Medical Affairs, Point-of-Care, Roche Molecular Systems
                                            Biography
                                              Joanna's background spans pharmaceutical, diagnostic and non-governmental organizations with a focus on public health and cost-effectiveness analytics to optimize medical value. As part of the Roche Molecular Diagnostics global medical affairs team she is responsible for developing and executing the point-of-care global medical plan including clinical impact and cost-effectiveness evidence development to support the uptake of new diagnostics. Prior to joining Roche at Zyomyx, she led market access strategy, policy and the post-approval clinical study program to support the launch of the Company's first product, a point-of-care CD4 test for use in limited resource settings. Previously, as part of the Access Programs leadership team at the Clinton Health Access Initiative (CHAI), she developed models and led advocacy for global procurement interventions to ensure the sustainability of the children's HIV drug market. She partnered with Ministries of Health throughout Africa to support the HIV Guidelines revision process and assess the cost impact of changes. She holds Masters in Public Health and Masters in Business Administration degrees from the University of California, Berkeley. She received her Bachelor of Arts degree from Wesleyan University.
                                            C.E. Credits

                                            The speakers below have been approved for CME, CE, or CEU credits. To redeem your credits, locate the presentation you watched and click on the CME/CE/CEU buttons for further direction. For more general information regarding continuing education, the processes to receive credits, and the accreditation bodies, Click here


                                            Committee

                                            To download the Program Committee brochure here.


                                            • Bryan Cobb

                                              Dr. Cobb is the acting Director for Clinical Molecular Diagnostics at Roche Diagnostics Corporation where he serves in a scientific advisory role supporting the laboratory scientific community. He obtained his Ph.D. in Medical Genetics at the University of Alabama at Birmingham ...

                                              See more See less
                                            • Shawn Baker

                                              Dr. Shawn C. Baker is the Chief Science Officer and co-founder of AllSeq. Having received his Ph.D. at the University of California - Davis, he started his career as a Research Scientist at Illumina when it was a 15-person startup. After spending several years at the bench ...

                                              See more See less
                                            • Emily Hollister

                                              Dr. Emily Hollister is a microbial ecologist and serves as the Vice President for Information Technology & Analytics at Diversigen, Inc. Prior to joining Diversigen, Dr. Hollister served as an Assistant Professor in the Department of Pathology & Immunology at Baylor College of ...

                                              See more See less
                                            • Christopher Mason

                                              Dr. Christopher Mason completed his dual B.S. in Genetics and Biochemistry (2001) from University of Wisconsin-Madison, his Ph.D. in Genetics (2006) from Yale University, and then completed post-doctoral training in clinical genetics (2009) at Yale Medical School, and a joint ...

                                              See more See less
                                            • Eugean Jiwanmall

                                              Eugean Jiwanmall's past professional experiences include basic science and clinical research. In his current role as a Senior Research Analyst for Medical Policy & Technology Evaluation at Independence Blue Cross' Claim Payment Policy Department within Facilitated Health ...

                                              See more See less
                                            • Khyati Shah

                                              Khyati Shah received her Ph.D. in Molecular Pharmacology from the University of the Pacific, Stockton, California. Her graduate research was completed in the lab of Jesika Faridi, Ph.D. Her work focused on the investigation of the mechanism of Akt induced tamoxifen resistance in ...

                                              See more See less
                                            Help

                                            General LabRoots Questions

                                            For bugs, spam, technical support or questions please call +1-714-463-4673 or email support@labroots.com  
                                            Contact us

                                            Virtual Events and Webinars

                                            Supported Configurations

                                            • Operating System Internet Explorer Firefox Chrome Safari
                                              Vista IE8+ FF10+ Chrome15+
                                              Windows 7 IE8+ FF10+ Chrome15+
                                              Windows 8 IE10 FF10+ Chrome15+
                                              Mac OS X   FF10+ Chrome15+ Safari5.1+
                                            • Cookie settings: session cookies enabled
                                            • Browser configuration must have JavaScript enabled
                                            • Adobe Flash player 10.2 or later

                                            To watch our webinars and virtual events a modern browser such as Chrome, Firefox, Safari, or an updated version of Internet Explorer is required.

                                            Internet Connection

                                            • A minimum of 100Kbps is recommended for audio-only events
                                            • A minimum of 300Kbps is recommended for speaker on-video events

                                            Computer Equipment

                                            • Screen Resolution: Minimum 1024x768
                                            • Video Card: 65,000 colors minimum
                                            • Sound card and speakers (or headphones) for hearing webcast in full format
                                            • Audio Card: 16-bit minimum
                                            • RAM: 512MB of free RAM

                                            Firewall Protocol

                                            • HTTP on port 80 or HTTPS on port 443
                                            • Adobe RTMP on port 1935, 80, or 443 with automatic fall-back to RTMPT (RTMP tunneling) on ports 1935, 80 or 443
                                            • RTMPE (RTMP encrypted) on ports 1935, 80 or 443

                                            Work-At-Home Attendees

                                            • If a corporate VPN is used, confirm that your network traffic is not directed over the company VPN. If it is, please turn off the VPN while attending the virtual event.

                                            For A Seamless Experience

                                            When using a mobile device, FREE Mobile Apps are available:

                                            - For viewing Webinars:

                                            - For viewing Virtual Events

                                            Attendee Guide

                                            • To learn more about how the virtual event works for attendees, download the Attendee Guide (PDF).

                                            Virtual Event and Webinar Support:

                                            Continuing Education (CME/CE) Support

                                            Loading Comments...
                                            Show Resources